| Cas No.: | 1904649-00-8 |
| Chemical Name: | (R)-6-(1-(tert-butyl)-1H-pyrazol-4-yl)-4-methyl-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one |
| Synonyms: | CPI-703;CPI 703 |
| Formula: | C17H22N4O |
| M.Wt: | 298.39 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A potent, selective, cell-active CBP/EP300 bromodomain inhibitor with IC50 of 0.47 uM for CBP; displays little to no (>200-fold selectivity) activity for BRD9, BRD4, BRPF1, TRIM24, BRG1 and BACF (IC50>10 uM); inhibits CBP bromodomain binding in a dose-dependent manner with cellular EC50 of 2.1 uM, reduces Treg differentiation and exhibits FOXP3 inhibition with IC50 of 1.5 uM, significantly affects TH17 differentiation, suppresses TH17 cytokines, IL-17A, IL-17F, and IL-21 with no effect on TNFα production or cell viability. |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
